Form D · Pharmaceuticals

Receptos, Inc.

San Diego, CA · CIK 0001463729

Offering snapshot reported Feb 17, 2012 · SEC filing

Reported sold
$10.8M
Offering amount: $50M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 3, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 17, 2012Initial$10,806,610No comparison11SEC filing
Nov 23, 2009Initial$11,999,999No comparison6SEC filing
May 22, 2009Initial$7,673,456No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-173676

Source: Form D, filed Feb 17, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Marcus Boehm Executive
Kristina Burow Director
Doug Cole Director
Paul Grayson Director
Sheila Gujrathi Executive
Faheem Hasnain Director, Executive
Chrysa Mineo Executive
Amir Nashat Director
Robert Nelsen Director
Robert Nelson Director
Robert Peach Executive
William Rastetter Director
James Schmidt Executive
Michael Sheffery Director
Raymond Stevens Director
Ed Torres Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
10835 Road To The Cure Suite 205
San Diego, CA, 92121